TID-ISODP Webinar - July 22, 2021

Deceased Donor SARS-CoV-2 Testing and Implications for Organ Acceptance

Thursday, July 22, 2021, 10:00 AM (Local time in Montreal)
Local time (Corresponding local time at your current location)

Overview

To date, there have been three reports of SARS-CoV-2 transmission to lung transplant recipients from donors who initially tested negative for SARS-CoV-2 infection by upper respiratory tract testing, underscoring the importance of lower respiratory tract testing in potential lung donors to improve patient safety. Simultaneously, given the growing proportion of the population that has been infected with SARS-CoV-2, there is an emerging need to recover organs from donors with prior infection to avoid unnecessary decline of otherwise suitable organs. This webinar will address the potential complexities of deceased donor SARS-CoV-2 testing and implications for organ acceptance.

Learning Objectives

  1. Describe the assessment of deceased donors for SARS-CoV-2 infection
  2. Understand OPO logistics and challenges related to SARS-CoV-2 evaluation of potential deceased donors
  3. Describe an approach to organ acceptance for deceased donors who test positive for SARS-CoV-2, including those with a history of COVID-19
Faissal Shaheen 
Moderator
Director General, SCOT
Saudi Center for Organ Transplantation
Saudi Arabia
Bio
Ines Ushiro-Lumb 
Speaker
Member of TTS, TID, ISODP, ESOT, ISBT
Consultant Clinical Virologist,
National Health Service Blood and Transplant, UK
Bio
Richard Hasz 
Speaker
Gift of Life Donor Program, USA
Bio
Ricardo La Hoz  
Speaker
Associate Professor of Internal Medicine,m
Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX
Bio

Contact

Staff Directory
+1-514-874-1717 , X : 216
sections@tts.org

Address

Transplant Infectious Disease
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada